Zoltán Kaló - Professor of Health Economics - Center for Health Technology Assessment, Semmelweis University | LinkedIn
PDF) Policy objective of generic medicines from the investment perspective: The case of clopidogrel
Sikereink
„A kulcs a tudatos tervezés”
Zoltán Kaló – Universal health: Investing in Health and Wellbeing for All
ELTE Reader
PDF) Implication of external price referencing and parallel trade on pharmaceutical expenditure: Indirect evidence from lower-income European countries
Rektori kiválósági különdíj - galéria
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
PDF) Need for Multicriteria Evaluation of Generic Drug Policies
Prof. Zoltán Kaló PhD András Borsi PhD(c)
EPHA on Twitter: ""#Valletta has not reached any real progress yet. We are exchanging knowledge, taking steps towards #transparency, but real progress is not yet there." Paola Testori Coggi @Aifa_ufficiale #Trailblazers2025" /
Sağlık Bilimleri Üniversitesi - Sağlık Ekonomisi Eğitimi Programı 2
ISPOR - Zoltán Kaló, PhD
ELTE Reader
kalo@tatk.elte.hu 1
II. ELTE Biotechnológia FIEK szimpózium
Health Care Challenges in Central & Eastern European Countries - YouTube
Könyv: Bevezetés a szerhasználó nők világába (Kaló Zsuzsa)
▻ Limited human resources and budget for HTA implementation ▻ At Western European prices medicines are usually not cost-effe
Health Policy, Planning and Financing MSc ELTE by ELTE TáTK - Issuu
ELTE Reader
Transferability of HTA between countries - ppt download
About us - Hungary - Selfie 2020 -
Colleagues – Center for Health Technology Assessment
ELTE Reader
Steps of economic evaluation Decision rule & sensitivity analysis - ppt download
Sağlık Bilimleri Üniversitesi - Sağlık Ekonomisi Eğitimi Programı 2
